SEBI: Exonerates Piramal Pharma for LODR violations, absent “materiality criteria” impacting market perception
Nov 11, 2024
|
Simply Register/Sign In to access the free content across the portals!
Not subscribed yet?
Gain access to unlimited paid content by subscribing to our portals